News|Articles|August 30, 2025
The Weekly Roundup: August 25-29
Author(s)Marie Bosslett, Assistant Editor
Listen
0:00 / 0:00
Key Takeaways
- mRNA technology is being explored for acne treatment, targeting inflammatory responses rather than symptoms.
- DecisionDx-SCC provides insights into metastasis risk, ART response, and recurrence risk in high-risk cSCC.
In case you missed it, this week we had news about the potential of an mRNA vaccine for acne, the clinical role of DecisionDx-SCC, the presence of global dermatology deserts, and more.
Advertisement
To stay up-to-date with the latest dermatology news, sign up to receive our
Explore common pediatric summer skin issues, from rashes to sun sensitivity, and learn effective prevention and management strategies for healthy skin.
Joshua Zeichner, MD, spoke to Dermatology Times about Sanofi's clinical trials for the world’s first mRNA acne vaccine, aiming to revolutionize treatment by targeting the body’s inflammatory response rather than just symptoms.
The test now provides 3 validated insights: risk of metastasis, response to ART, and risk of recurrence.
Find out what skin care products and aesthetic innovations clinicians are recommending to patients for the month of August.
Roundtable participants agreed the art of psoriasis management lies in aligning biologic or oral options with patient comorbidities, lifestyle, and insurance coverage.
From remote villages to island nations, a WHA resolution and grassroots efforts aim to bridge care gaps in regions lacking access to dermatology providers.
Discover how biologic coordinators streamline dermatologic care through detailed protocols, clinical documentation, and patient advocacy to improve access to life-changing biologic therapies.
Explore the top headlines of the month, including insights on regulatory updates, expert pearls, and more.
Andrew Baker, MBA, MPAS, PA-C, discusses new data highlighting both the growing challenges—like burnout and reimbursement cuts—and exciting opportunities in leadership, virtual care, and mentorship for PAs and NPs.
This review of the latest dermatologic studies focuses on chronic spontaneous urticaria with new research on the transition from omalizumab to dupilumab, metabolic syndrome in urticaria patients, current pediatric CSU guidelines, and more.
Explore innovative biologic treatments for prurigo nodularis, enhancing patient quality of life and breaking the itch-scratch cycle effectively.
Key regulatory milestones for MAL-838, a novel sCD83-based, hormone-free hair growth ingredient, are paving the way for the market launch of a microbiome-friendly 8T3 product line.
Learn more about the in-depth topics covered in the August 2025 print issue of Dermatology Times.
Lisa Swanson, MD, FAAD, shares innovative insights on pediatric dermatology, emphasizing effective treatments and communication strategies for young patients at DERM 2025.
Explore essential long-term care insurance options for dermatologists, ensuring financial security and peace of mind for future healthcare needs.
Discover the latest in regenerative aesthetics and body contouring at DERM 2025, featuring insights from Suneel Chilukuri, MD, on skin care trends and biohacking.
Dermatology Times is recapping our exclusive expert interviews from the month of August.
Advances in biologics and systemics have reshaped the lives of patients with psoriasis, offering clearer skin and joint protection.
Research highlights that educational videos on standardized clinical photography protocols significantly lead to better management and treatment outcomes for patients with alopecia.
Discover how bond-building hair care treatments enhance hair strength and resilience, utilizing innovative technologies for healthier, more vibrant locks.
Katrina Lee, MD, discussed innovative strategies and challenges in managing HS at the Dermatology Innovation Symposium, emphasizing early intervention and comprehensive care.
Explore the latest breakthroughs in treatment and research during Hair Loss Awareness Month, enhancing understanding and patient care for hair loss disorders.
Test your knowledge of key words and terms associated with dermatology news from the last month.
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Related Content
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Clascoterone 5% Delivers Strong Phase 3 Hair-Growth Results
2
Derm Dispatch: What 'Free to Be Me' Means to Tori Spelling and Stella McDermott
3
Reviewing Type 2 Inflammation Through a Different Lens
4
Alpha-9 Begins First-in-Human Trial of MC1R-Targeted Radiotherapeutic
5
